These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14159974)

  • 1. THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST FALCIPARUM MALARIA.
    CONTACOS PG; COATNEY GR; LUNN JS; KILPATRICK JW
    Am J Trop Med Hyg; 1964 May; 13():386-90. PubMed ID: 14159974
    [No Abstract]   [Full Text] [Related]  

  • 2. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.
    COATNEY GR; CONTACOS PG; LUNN JS
    Am J Trop Med Hyg; 1964 May; 13():383-5. PubMed ID: 14159973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiments with antimalarial drugs in man. I. The protective effect of proguanil (paludrine) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae.
    THOMAS AT; ROBERTSON GI; DAVEY DG
    Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):338-45. PubMed ID: 13090297
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND.
    POWELL RD; BREWER GJ; ALVING AS; MILLAR JW
    Bull World Health Organ; 1964; 30(1):29-44. PubMed ID: 14128765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.